| related words |
| novartis |
| neither |
| endpoint |
| frame |
| announce |
| genentech |
| commencing |
| insulin |
| clinically |
| undergo |
| validated |
| tm |
| repeat |
| forming |
| flavor |
| kit |
| relying |
| xr |
| investigator |
| riquent |
|
| related documents |
| 790708--4/3/2006--IMPCO_TECHNOLOGIES_INC |
| 716054--3/16/2009--CYPRESS_BIOSCIENCE_INC |
| 1322505--12/14/2010--Biodel_Inc |
| 1444570--12/17/2010--Axcan_Intermediate_Holdings_Inc. |
| 730255--5/6/2010--CalAmp_Corp. |
| 875320--2/19/2010--VERTEX_PHARMACEUTICALS_INC_/_MA |
| 1407539--2/25/2010--Liberty_Acquisition_Holdings_Corp. |
| 1300514--3/1/2010--LAS_VEGAS_SANDS_CORP |
| 1156871--3/10/2010--INTELSAT_S.A. |
| 1055726--3/26/2010--INOVIO_BIOMEDICAL_CORP |
| 749647--3/17/2010--Celsion_CORP |
| 716054--3/31/2010--CYPRESS_BIOSCIENCE_INC |
| 885590--2/26/2010--BIOVAIL_CORP_INTERNATIONAL |
| 1178879--3/10/2010--AMICUS_THERAPEUTICS_INC |
| 1160308--3/18/2010--ADVENTRX_PHARMACEUTICALS_INC |
| 1322505--12/14/2009--Biodel_Inc |
| 1409383--6/15/2009--Global_Brands_Acquisition_Corp. |
| 1142380--4/15/2009--CALLISTO_PHARMACEUTICALS_INC |
| 875320--2/17/2009--VERTEX_PHARMACEUTICALS_INC_/_MA |
| 1405082--3/13/2009--Triplecrown_Acquisition_Corp. |
|
| related topics |
| {product, candidate, development} |
| {interest, director, officer} |
| {customer, product, revenue} |
| {control, financial, internal} |
| {debt, indebtedness, cash} |
| {tax, income, asset} |
| {system, service, information} |
| {cost, contract, operation} |
| {financial, litigation, operation} |
| {personnel, key, retain} |
| {product, market, service} |
| {loss, insurance, financial} |
| {competitive, industry, competition} |
| {cost, operation, labor} |
| {product, liability, claim} |
| {regulation, government, change} |
| {stock, price, share} |
| {gas, price, oil} |
| {condition, economic, financial} |
| {acquisition, growth, future} |
|